These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36541819)

  • 1. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils.
    Leal VNC; Andrade MMS; Teixeira FME; Cambui RAG; Roa MEGV; Marra LG; Yamada SM; Alberca RW; Gozzi-Silva SC; Yendo TM; Netto LC; Duarte AJS; Sato MN; Pontillo A
    Scand J Immunol; 2023 Mar; 97(3):e13247. PubMed ID: 36541819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19].
    Ren Z; Che P; Li Z; Mo M; Zhang S; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):844-850. PubMed ID: 34533131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
    Bertoni A; Penco F; Mollica H; Bocca P; Prigione I; Corcione A; Cangelosi D; Schena F; Del Zotto G; Amaro A; Paladino N; Pontali E; Feasi M; Signa S; Bustaffa M; Caorsi R; Palmeri S; Contini P; De Palma R; Pfeffer U; Uva P; Rubartelli A; Gattorno M; Volpi S
    J Allergy Clin Immunol; 2022 Oct; 150(4):796-805. PubMed ID: 35835255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection].
    Chemarin M; Dufies O; Mazet A; Mellan E; Coudereau R; Py BF; Boyer L; Venet F
    Med Sci (Paris); 2022; 38(6-7):545-552. PubMed ID: 35766852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.
    Xu H; Akinyemi IA; Chitre SA; Loeb JC; Lednicky JA; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Mar; 568():13-22. PubMed ID: 35066302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications.
    Potere N; Del Buono MG; Caricchio R; Cremer PC; Vecchié A; Porreca E; Dalla Gasperina D; Dentali F; Abbate A; Bonaventura A
    EBioMedicine; 2022 Nov; 85():104299. PubMed ID: 36209522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals.
    Houshmandfar S; Khodadadi A; Mahmoudian-Sani MR; Nashibi R; Rashno M
    Immunobiology; 2023 Sep; 228(5):152710. PubMed ID: 37478686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
    Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
    Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2.
    Barnett KC; Xie Y; Asakura T; Song D; Liang K; Taft-Benz SA; Guo H; Yang S; Okuda K; Gilmore RC; Loome JF; Oguin Iii TH; Sempowski GD; Randell SH; Heise MT; Lei YL; Boucher RC; Ting JP
    Cell Host Microbe; 2023 Feb; 31(2):243-259.e6. PubMed ID: 36563691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity.
    Amin S; Aktar S; Rahman MM; Chowdhury MMH
    Microbes Infect; 2022 Feb; 24(1):104913. PubMed ID: 34838941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils Facilitate Prolonged Inflammasome Response in the DAMP-Rich Inflammatory Milieu.
    Son S; Yoon SH; Chae BJ; Hwang I; Shim DW; Choe YH; Hyun YM; Yu JW
    Front Immunol; 2021; 12():746032. PubMed ID: 34659244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
    Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies.
    He Q; Hu D; Zheng F; Chen W; Hu K; Liu J; Yao C; Li H; Wei Y
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF; Te Velde AA
    Front Immunol; 2020; 11():1580. PubMed ID: 32670297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases.
    Paget C; Doz-Deblauwe E; Winter N; Briard B
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
    Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
    Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore.
    Guarnieri JW; Angelin A; Murdock DG; Schaefer P; Portluri P; Lie T; Huang J; Wallace DC
    Front Immunol; 2023; 14():1064293. PubMed ID: 36891303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.